Literature DB >> 27578618

Controversy of oral hypoglycemic agents in type 2 diabetes mellitus: Novel move towards combination therapies.

Abhijit A Ghadge1, Aniket A Kuvalekar2.   

Abstract

AIM: As diabetes mellitus is multi-factorial disease, use of several oral hypoglycemic agents (OHAs) is the main stay of pharmacological treatment. The treatment has become more challenging and controversial as OHAs are heterogeneous in their mode of action that causes unwanted side effects. Complementary approaches such as use of medicinal plants and dietary polyunsaturated fatty acids (PUFA) with hypoglycemic and hypolipidemic activities are therefore imperative. A vast literature has independently documented the effects of OHAs, medicinal plants and PUFA for management of diabetes. In the present article, we have reviewed the current literature to describe the effects of commonly used OHAs, their mechanisms of action and reported controversies. The antidiabetic potential of herbs and/or formulations and omega-3 PUFA with its potential benefits and mode of action is also discussed.
METHODS: PUBMED, MEDLINE, Cochrane Library etc., were searched for relevant articles using appropriate terms (until February 2015). Human and animal studies were selected for the review. Data extraction was carried out by one author and checked by second author.
RESULTS: There is still controversy over the safety profile of OHAs. Medicinal herbs with hypoglycemic activities are increasingly sought because of its natural origin, active constituents and minimal side effects. The current literature suggests that supplementation with PUFA improves macro- and microvascular complications.
CONCLUSION: There is a need for best possible individualized treatment based on variations in biochemical parameters with combinational therapy of nutritional/herbal supplementations. Such a combination may be helpful for better management of diabetes and its complications.
Copyright © 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Medicinal plants; Omega-3 fatty acids; Oral hypoglycemic agent

Mesh:

Substances:

Year:  2016        PMID: 27578618     DOI: 10.1016/j.dsx.2016.08.009

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  5 in total

1.  Gender dependent differences in lipid metabolism in individuals with type 2 diabetes mellitus.

Authors:  Abhijit A Ghadge; Abhay M Harsulkar; Arundhati G Diwan; Aniket A Kuvalekar
Journal:  J Diabetes Metab Disord       Date:  2020-07-15

Review 2.  Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.

Authors:  Murugan Prasathkumar; Robert Becky; Salim Anisha; Chenthamara Dhrisya; Subramaniam Sadhasivam
Journal:  Biotechnol Lett       Date:  2022-02-04       Impact factor: 2.461

3.  Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Authors:  Emanuel L Peter; Serawit Deyno; Andrew Mtewa; Félicien Mushagalusa Kasali; Prakash B Nagendrappa; Duncan Sesaazi; Casim Umba Tolo; Patrick Engeu Ogwang
Journal:  Syst Rev       Date:  2018-11-15

4.  The Effects of C. lacerata on Insulin Resistance in Type 2 Diabetes Patients.

Authors:  Arim Choi; Jung Hye Kim; Hye-Kyung Chung; Chul Woo Ahn; Hee Joon Choi; Yu-Sik Kim; Ji Sun Nam
Journal:  J Diabetes Res       Date:  2022-02-22       Impact factor: 4.011

5.  Effects of Spirulina platensis on insulin secretion, dipeptidyl peptidase IV activity and both carbohydrate digestion and absorption indicate potential as an adjunctive therapy for diabetes.

Authors:  J M A Hannan; Prawej Ansari; Shofiul Azam; Peter R Flatt; Yasser H A Abdel Wahab
Journal:  Br J Nutr       Date:  2020-06-10       Impact factor: 3.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.